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DrWei Zhou (Stanford, Calif). My first question is regarding
compatibility of the two groups of patients. Several risk factors
including congestive heart failure (CHF), chronic renal failure, and
chronic obstructive pulmonary disease (COPD) are known to
negatively impact carotid interventions, but these were not evalu-
ated in this study. Based on the Kaplan-Meier survival curve of your
patients, male patients had a significant drop out at 6 months while
female patients tended to drop out around 20 months. So my first
question is whether you really compared similar groups of patients?
Is outcome of carotid artery stenting (CAS) for female patients
truly equivocal to men, or they are just healthier than their male
counterparts?
You mentioned that the indications for significant stenosis
were based on ultrasound scan, magnetic resonance angiography
(MRA), and carotid angiogram. Giving the fact that MRA tends to
overestimate the lesions and ultrasound scan is a fairly good
non-invasive screen tool, my second question is: Why an ultra-
sound scan was not used for all patients and were those imaging
studies validated and cross-referenced?
In your manuscript, you mentioned that the size of your
predilatation balloon was uniformly 4 mm  50 mm. The size is a
little bigger than most surgeons would have used. Were there any
reasons for oversizing the predilatation balloon?
The last question is regarding ultrasound scan characteristics
of lesions. Studies have shown that ultrasound scan characteristics
are important, maybe more so than the degree of stenosis. Have
you looked into and will you plan to evaluate ultrasound scan
characteristics of the lesion in the future?
Dr Lee Goldstein. To begin, let me address your first ques-
tion. As far as other preoperative characteristics, we have been
actively trying to pursue the maintenance of our dataset and we
have been trying to add to some of the preoperative characteristics.
I agree, one of the troubles we’ve had has been many of the
patients we’ve done our carotid angioplasty and stenting on have
come as referrals from other medical centers, so we have been
trying to look back and get more data on these patients. Adding
things like congestive heart failure, renal failure, and COPDwould
shed some light on whether or not these patients are different.
One thing that struck us was the remarkable similarity be-
tween our patient populations. As we processed this data, we were
surprised to see just how close they were, that we saw so few
differences. So I agree, adding more data points will be helpful and
we will go back and try to do that.
With regard to preoperative workup, I don’t have the break-
down as to which patients were evaluated preoperatively by MRA
angiography vs ultrasound. Anecdotally, I can tell you the vast
majority of these patients were evaluated with a preoperative
ultrasound scan and then that was confirmed with or without an
MRA or angiography. Every one of them underwent angiography
prior to the placement of a carotid stent during the procedure, so
the lesion was confirmed intraoperatively prior to placement of the
carotid stent. I don’t think any of them had solely an MRA. But
they all had a preoperative duplex scan and then a preplacementWith regard to the predilatation balloon, that may be an error
in the manuscript. I believe it’s a 4  20 balloon. And we’ll make
sure that we address that.
And lastly, as far as ultrasound scan characteristics, I think
that there has been some recent literature looking both at
specifically female-related ultrasound scan characteristics, that
females demonstrate higher velocities with regard to specific
lesion characteristics, and that females will demonstrate higher
velocities for specific stenosis sizes. We have not yet gone back
and evaluated our particular ultrasound scan characteristics for
these patients.
Additionally, there has been some new data looking at evalu-
ation of post carotid stenting ultrasound scan characteristics and
velocities. We can go back and look specifically at those issues as
well.
Dr Anil Hingorani (Brooklyn, NY). How many of your
patients that had strokes didn’t have embolic protection devices,
and why didn’t they?
Dr Goldstein. There were no patients that suffered a stroke
that didn’t have an embolic protection device.
Dr Hingorani. You had a fair number that didn’t have
embolic protection devices used. What were the reasons?
Dr Goldstein. There were 13 patients in the study without
embolic protection devices. I don’t know the reasons why they
didn’t at the time.
Dr Hingorani. All of the strokes occurred without embolic
protection?
DrGoldstein.No. Every patient who suffered a stroke had an
embolic protection device placed.
Dr Karl Illig (Rochester, NY). Dr. Goldstein, luckily your
ages are the same in each group so your conclusions aren’t affected,
but can you defend your choice of age over 80 as a high-risk criteria
for surgery or, in other words, why you feel stenting is safer than
endarterectomy in elderly patients? I would say the opposite is true.
DrGoldstein. I would agree. I don’t know. This has been the
high-risk group that has been used for our institution in our carotid
stenting group.
Dr Illig. Can you defend that?
Dr Ageliki Vouyouka (New York, NY). The data collection
of this study started early in 2003. At that time, the worst out-
comes from carotid stenting in octogenarians, as shown in the lead
in phase of the CREST trial, were not yet known. Therefore,
initially, one of the high-risk criteria to consider carotid stenting
was age 80 years. This criterion was abandoned in later years.
Dr Taras Kucher (Trumbull, Conn). In this study, both
males and females had approximately 4-mm size carotid arteries. It
is postulated in prior publications, that the increased risk of com-
plications in women (particularly re-stenosis) is secondary to
smaller size of the vessels. Do you have an explanation for this
discrepancy?
Dr Goldstein. Correct. We’ve noted a number of papers that
have demonstrated women to have smaller carotid arteries. In fact,
that’s the hypothesis as to why they’ve done poorly surgically, that
technically they’ve had harder arteries to work with and why
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independently to review the angiographic data and they got similar
measurements. So I can’t explain why our cohort had these results,
but we had in fact similar sizes between themen and the women forWe did have similar findings as other groups, although they
didn’t reach significance, for internal carotid to common carotid
ratios, and for outflow to inflow ratios for women compared to
men. But as far as absolute sizes, we did not demonstrate athe internal carotids. difference between men and women.
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